Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach

Documenti analoghi

• Duchenne muscular dystrophy: CRISPR/Cas9 treatment
  di: Mendell, Jerry R, et al.
  Pubblicazione: (2016)
• Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
  di: Lim, Kenji Rowel Q., et al.
  Pubblicazione: (2018)
• Multiplex CRISPR/Cas9-Based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy
  di: Ousterout, David G., et al.
  Pubblicazione: (2015)
• Promising therapeutic approaches using CRISPR/Cas9 genome editing technology in the treatment of Duchenne muscular dystrophy
  di: Mollanoori, Hasan, et al.
  Pubblicazione: (2020)
• CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo
  di: Duchêne, Benjamin L., et al.
  Pubblicazione: (2018)